Ramsay finalises French acquisition

March 29, 2010

Ramsay Health Care Limited (RHC) said it has finalised its acquisition of a 57% interest in leading French private hospital operator Groupe Proclif SAS after meeting the requisite regulatory approvals. On 11 January this year Ramsay announced it had agreed to purchase the majority stake in Proclif for €87 million, marking Ramsay’s first acquisition in Continental Europe.

The company said Proclif is the second largest hospital group in the Paris region, comprising nine acute hospitals in the fields of medicine, surgery and obstetrics and generating annual revenue of approximately €133 million.

The remaining 43% interest in Proclif is held by Crédit Agricole Assurances personal insurance arm Predica.

Ramsay said as part of the acquisition it has entered into a long-term partnership with Predica to grow the business and build a portfolio of hospitals in the French acute care sector.

Ramsay managing director, Christopher Rex, said the market dynamics are very attractive in France, which has an integrated private and public hospital system, a strong regulatory framework and sustainable funding regime.

“Of particular importance to Ramsay is the highly fragmented nature of the French hospital market which has more than 400 small private operators,” Mr Rex said.

“This presents significant opportunities for Ramsay to expand its quality portfolio of hospitals in France and apply its proven model and management expertise.”

The company expects the acquisition to deliver a small accretion to core EPS by FY12, with more significant EPS accretion anticipated as future acquisitions are made.

Ramsay also reaffirmed guidance for core NPAT growth of 18%-20% for the group for FY10, translating to core EPS growth of 10%-12%.

As at 1038 AEDT, Ramsay shares were unchanged at $13.98.

0

Director Interest Notices – 29 March 2010

March 29, 2010

Directors' Interest Notices
29 March 2010

Symbol

Shareholder

+/-

Prior

Now

BBG 

Paul Naude

  

1,348,015

1,278,015 

CXP 

Paul Warren Hitchcock

  

10,000 

153,590 

CXP

Grant Logan

  

36,212

186,719

CYG 

Roger Baden Flynn

  

195,035 

189,574 

CYG

John Harold Nickson

  

92,492

94,840

CYG

Barry Frederick Nazer

  

101,532

104,420

LEI 

Dieter Siegfried Adamsas

  

246,851 

226,851

LEI 

Wallace Macarthur King

  

336,660

320,000

 

0

Substantial Shareholder Changes – 29 March 2010

March 29, 2010

Substantial Shareholder Changes 
29 March 2010

Symbol

Shareholder

+/-

Prior

Now

AOE 

Bank of America Corporation

 

6.48 

7.57 

MCC 

Credit Agricole Luxembourg SA

   

16.61 

- 

NUF 

Sumitomo Chemical Company

 

8.73 

20.00 

QBE 

BlackRock Investment Mgt.

 

5.13 

- 

SGM 

M&G Investment Funds

 

12.05 

13.04 

0

RBS: QBE – Valuation looks compelling

March 29, 2010

RBS – Round Up – 300310

0

RBS: QBE – Valuation looks compelling

March 29, 2010

RBS – Round Up – 300310

0

NAB shares halted

March 29, 2010

National Australia Bank Limited (NAB) requested its shares be placed in trading halt due to a pending announcement regarding the status of contractual negotiations to acquire the Australian and New Zealand businesses of AXA Asia Pacific Limited (AXA). NAB has been in talks with AXA APH French parent, AXA SA, with a deadline for finalising a deal passed yesterday.

AXA SA owns 53.9% of the target, with the proposal being a $13.3 billion takeover bid to buy its Asian operations.

NAB said the trading halt would remain in place until the commencement of trading on Wednesday, 31 March 2010, or such earlier time agreed by ASX.

NAB shares were halted at $27.70, while AXA APH shares were halted at $6.35.

0

NAB shares halted

March 29, 2010

National Australia Bank Limited (NAB) requested its shares be placed in trading halt due to a pending announcement regarding the status of contractual negotiations to acquire the Australian and New Zealand businesses of AXA Asia Pacific Limited (AXA). NAB has been in talks with AXA APH French parent, AXA SA, with a deadline for finalising a deal passed yesterday.

AXA SA owns 53.9% of the target, with the proposal being a $13.3 billion takeover bid to buy its Asian operations.

NAB said the trading halt would remain in place until the commencement of trading on Wednesday, 31 March 2010, or such earlier time agreed by ASX.

NAB shares were halted at $27.70, while AXA APH shares were halted at $6.35.

0

In Brief: 30 March 2010 – LLC

March 29, 2010

Lend Lease Group (LLC) announced the completion of its fully underwritten $806 million equity raising by way of a 5 for 22 single Entitlement Offer and the result of the Shortfall Bookbuild. The group said 28,206,762 new securities were offered at $8.60 per new share under the Shortfall Bookbuild conducted on yesterday. Lend Lease said this price represented a discount of 1.4% to the last traded price of the group’s shares and a premium of 90c or 11.7% to the Entitlement Offer price of $7.70 per new security. The group said this premium would be returned to renounced eligible institutional and retail shareholders and to ineligible shareholders on or about Friday, 9 April 2010.

0

In Brief: 30 March 2010 – LLC

March 29, 2010

Lend Lease Group (LLC) announced the completion of its fully underwritten $806 million equity raising by way of a 5 for 22 single Entitlement Offer and the result of the Shortfall Bookbuild. The group said 28,206,762 new securities were offered at $8.60 per new share under the Shortfall Bookbuild conducted on yesterday. Lend Lease said this price represented a discount of 1.4% to the last traded price of the group’s shares and a premium of 90c or 11.7% to the Entitlement Offer price of $7.70 per new security. The group said this premium would be returned to renounced eligible institutional and retail shareholders and to ineligible shareholders on or about Friday, 9 April 2010.

0

Citi upgrades NAB

March 29, 2010

Citigroup has upgraded NAB (BUY, price target $30.50) and raised its price target, arguing that recent sharemarket weakness has presented a buying opportunity. The broker says that concerns about execution risk regarding the potential AXA transaction were overdone.

Citi also said that the market is pricing in UK acquisition risk, which is also overdone. The broker said investors are concerned that NAB will add to its franchise before exiting the UK. However, Citi said NAB is likely to simply ride out the currency and bad debt cycle before exiting.

Moreover, Citi believes that NAB’s medium term outlook is promising. The company said it would benefit from a broader wealth management platform, improvement in commercial lending and the UK currency in FY11 and beyond.

Based on the a number of Citi’s valuation metrics, the broker concluded that NAB should be priced around $30.50, ahead of the yesterday’s closing price of $27.70.

0